Edarbi
Brand for: Azilsartan
My Prescription
Payment
Select pharmacy
$73.08
Print or send this coupon to your phone
WalgreensPowered byAbout Edarbi
Drug Details
Azilsartan, marketed as Edarbi, is a medication prescribed for managing high blood pressure (hypertension) in adults. By reducing high blood pressure, it helps prevent serious health issues such as strokes, heart attacks, and kidney damage. Azilsartan belongs to a group of medications known as angiotensin II receptor blockers (ARBs). It functions by inhibiting the hormone angiotensin II, which results in the relaxation of blood vessels and an easier blood flow. Typically, azilsartan is administered in a tablet form with a recommended dosage of 40 mg to 80 mg once daily. While it generally does not cause weight gain, some users may experience side effects like diarrhea, nausea, or fatigue. Always consult your healthcare provider before starting any new medication or treatment.
Price history for Edarbi (brand) & Azilsartan (generic)
30 Tablets, 80MG
Average retail price for Edarbi
Average retail price for Azilsartan
Average SaveHealth price for Azilsartan
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Edarbi is $216.68 using the SaveHealth savings card. That's an average savings of 36.39% on Edarbi with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Edarbi (Azilsartan) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG | 30 Tablets | $107.71 | $3.59 |
| 80MG | 30 Tablets | $120.25 | $4.01 |
Edarbi FAQs
Edarbi (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) used to treat high blood pressure. It is considered effective for lowering blood pressure and is generally well-tolerated. However, the suitability of Edarbi for an individual depends on their specific health condition, medical history, and any other medications they may be taking. It is important for patients to consult with their healthcare provider to determine if Edarbi is the right medication for their needs.
The cost of Edarbi can be attributed to several factors. These may include the research and development expenses involved in bringing the medication to market, the costs associated with clinical trials, and the regulatory processes required for approval. Additionally, pricing can be influenced by the drug's patent status, manufacturing costs, and market exclusivity. Insurance coverage and pharmacy pricing strategies may also impact the out-of-pocket cost for patients.
Edarbi (azilsartan medoxomil) can potentially affect kidney function, especially in individuals with pre-existing kidney conditions. It is important for patients to have their kidney function monitored regularly while taking this medication. If there are any concerns about kidney health, it is advisable to consult a healthcare provider for personalized advice and management.
The generic name for Edarbi is azilsartan medoxomil.
The choice between Losartan and Edarbi (azilsartan) depends on the individual patient's medical condition, response to treatment, and any underlying health issues. Both medications are angiotensin II receptor blockers (ARBs) used to treat high blood pressure. The effectiveness and side effects can vary from person to person. A healthcare provider would consider factors such as the patient's overall health, other medications they are taking, and their specific health needs before determining which medication is more suitable. It is important for patients to consult with their healthcare provider to decide which medication is best for their situation.